INVESTOR NEWS

Mar 12, 2025

Key information relating to the proposed cash dividend

Moss, 12 March 2025

Mar 10, 2025

Gentian Diagnostics and Beckman Coulter Partner to Launch Gentian GCAL® Calprotectin Immunoassay

Moss,10 March 2025

Mar 03, 2025

Mandatory notification of trade

Moss, 3 March 2025

Mar 03, 2025

Notification of trade

Moss, 3 March 2025

Mar 03, 2025

Disclosure of large shareholding in Gentian Diagnotics ASA

Gentian Diagnostics ASA - Disclosure of Large Shareholding Oslo, Norway, March 3, 2025

Mar 03, 2025

Disclosure of shareholdings – Holta Invest AS

3 March 2025

Feb 12, 2025

Fourth quarter 2024 report

Moss, 12 February 2025

Feb 05, 2025

Invitation to presentation of fourth quarter results

Gentian Diagnostics ASA will present its fourth quarter 2024 results on 12 February 2025 at 10.00 CET.

Dec 16, 2024

Mandatory notification of trade

Moss, 16 December 2024

Dec 04, 2024

Financial calendar

Financial calendar for Gentian Diagnostics ASA